Cargando…
Molecular mutagenesis of ppGpp: turning a RelA activator into an inhibitor
The alarmone nucleotide (p)ppGpp is a key regulator of bacterial metabolism, growth, stress tolerance and virulence, making (p)ppGpp-mediated signaling a promising target for development of antibacterials. Although ppGpp itself is an activator of the ribosome-associated ppGpp synthetase RelA, severa...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5291098/ https://www.ncbi.nlm.nih.gov/pubmed/28157202 http://dx.doi.org/10.1038/srep41839 |
_version_ | 1782504728104534016 |
---|---|
author | Beljantseva, Jelena Kudrin, Pavel Jimmy, Steffi Ehn, Marcel Pohl, Radek Varik, Vallo Tozawa, Yuzuru Shingler, Victoria Tenson, Tanel Rejman, Dominik Hauryliuk, Vasili |
author_facet | Beljantseva, Jelena Kudrin, Pavel Jimmy, Steffi Ehn, Marcel Pohl, Radek Varik, Vallo Tozawa, Yuzuru Shingler, Victoria Tenson, Tanel Rejman, Dominik Hauryliuk, Vasili |
author_sort | Beljantseva, Jelena |
collection | PubMed |
description | The alarmone nucleotide (p)ppGpp is a key regulator of bacterial metabolism, growth, stress tolerance and virulence, making (p)ppGpp-mediated signaling a promising target for development of antibacterials. Although ppGpp itself is an activator of the ribosome-associated ppGpp synthetase RelA, several ppGpp mimics have been developed as RelA inhibitors. However promising, the currently available ppGpp mimics are relatively inefficient, with IC(50) in the sub-mM range. In an attempt to identify a potent and specific inhibitor of RelA capable of abrogating (p)ppGpp production in live bacterial cells, we have tested a targeted nucleotide library using a biochemical test system comprised of purified Escherichia coli components. While none of the compounds fulfilled this aim, the screen has yielded several potentially useful molecular tools for biochemical and structural work. |
format | Online Article Text |
id | pubmed-5291098 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Nature Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-52910982017-02-07 Molecular mutagenesis of ppGpp: turning a RelA activator into an inhibitor Beljantseva, Jelena Kudrin, Pavel Jimmy, Steffi Ehn, Marcel Pohl, Radek Varik, Vallo Tozawa, Yuzuru Shingler, Victoria Tenson, Tanel Rejman, Dominik Hauryliuk, Vasili Sci Rep Article The alarmone nucleotide (p)ppGpp is a key regulator of bacterial metabolism, growth, stress tolerance and virulence, making (p)ppGpp-mediated signaling a promising target for development of antibacterials. Although ppGpp itself is an activator of the ribosome-associated ppGpp synthetase RelA, several ppGpp mimics have been developed as RelA inhibitors. However promising, the currently available ppGpp mimics are relatively inefficient, with IC(50) in the sub-mM range. In an attempt to identify a potent and specific inhibitor of RelA capable of abrogating (p)ppGpp production in live bacterial cells, we have tested a targeted nucleotide library using a biochemical test system comprised of purified Escherichia coli components. While none of the compounds fulfilled this aim, the screen has yielded several potentially useful molecular tools for biochemical and structural work. Nature Publishing Group 2017-02-03 /pmc/articles/PMC5291098/ /pubmed/28157202 http://dx.doi.org/10.1038/srep41839 Text en Copyright © 2017, The Author(s) http://creativecommons.org/licenses/by/4.0/ This work is licensed under a Creative Commons Attribution 4.0 International License. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ |
spellingShingle | Article Beljantseva, Jelena Kudrin, Pavel Jimmy, Steffi Ehn, Marcel Pohl, Radek Varik, Vallo Tozawa, Yuzuru Shingler, Victoria Tenson, Tanel Rejman, Dominik Hauryliuk, Vasili Molecular mutagenesis of ppGpp: turning a RelA activator into an inhibitor |
title | Molecular mutagenesis of ppGpp: turning a RelA activator into an inhibitor |
title_full | Molecular mutagenesis of ppGpp: turning a RelA activator into an inhibitor |
title_fullStr | Molecular mutagenesis of ppGpp: turning a RelA activator into an inhibitor |
title_full_unstemmed | Molecular mutagenesis of ppGpp: turning a RelA activator into an inhibitor |
title_short | Molecular mutagenesis of ppGpp: turning a RelA activator into an inhibitor |
title_sort | molecular mutagenesis of ppgpp: turning a rela activator into an inhibitor |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5291098/ https://www.ncbi.nlm.nih.gov/pubmed/28157202 http://dx.doi.org/10.1038/srep41839 |
work_keys_str_mv | AT beljantsevajelena molecularmutagenesisofppgppturningarelaactivatorintoaninhibitor AT kudrinpavel molecularmutagenesisofppgppturningarelaactivatorintoaninhibitor AT jimmysteffi molecularmutagenesisofppgppturningarelaactivatorintoaninhibitor AT ehnmarcel molecularmutagenesisofppgppturningarelaactivatorintoaninhibitor AT pohlradek molecularmutagenesisofppgppturningarelaactivatorintoaninhibitor AT varikvallo molecularmutagenesisofppgppturningarelaactivatorintoaninhibitor AT tozawayuzuru molecularmutagenesisofppgppturningarelaactivatorintoaninhibitor AT shinglervictoria molecularmutagenesisofppgppturningarelaactivatorintoaninhibitor AT tensontanel molecularmutagenesisofppgppturningarelaactivatorintoaninhibitor AT rejmandominik molecularmutagenesisofppgppturningarelaactivatorintoaninhibitor AT hauryliukvasili molecularmutagenesisofppgppturningarelaactivatorintoaninhibitor |